Work for Phathom Pharmaceuticals, Inc.?

Claim Your Profile

Phathom Pharmaceuticals, Inc. Logo Image

Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals, Inc. Banner Image

Most Recent Annual Report

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

2019 Annual Report and Form 10K

Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals, Inc. has reached its limit for free report views.

About Phathom Pharmaceuticals, Inc.

11-50 Employees
Based in Florham Park, New Jersey

Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. Phathom has in-licensed the exclusive rights in the United States, Europe, and Canada to vonoprazan, a novel potassium competitive acid blocker (P-CAB) in late-stage development for the treatment of acid-related disorders.

Ticker:
PHAT
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol